Where does Sebastian Brunemeier work?

Sebastian Brunemeier is General Partner at Healthspan Capital.

What check size does Sebastian Brunemeier write?

Sebastian Brunemeier typically writes checks of $250K – $750K.

Where did Sebastian Brunemeier go to school?

Sebastian Brunemeier studied at University of Oxford (PhD (DPhil) studies (ABD), Biochemistry of aging. Clarendon Scholarship); Scripps Research (Skaggs-Oxford Scholar Fellowship (joint PhD program with Oxford, awarded but paused)); University of Amsterdam (MSc, Biomedical Science (Molecular Neuroscience)).

Sebastian Brunemeier

Investor

General Partner at Healthspan Capital · Venture Scout at PICUS CAPITAL

Oxford, United Kingdom

Writes $250K – $750K checks · typically $500K

Find your path to Sebastian

4,377 people in our graph share verified history with Sebastian — schools, employers, funds. One of them is your warm intro.

Bastian HasslingerunlockedSebastian: together at PICUS CAPITAL (2021–2022)

Sebastian: together at PICUS CAPITAL

×2Sebastian: together at McKinsey & Company

×5Sebastian: together at University of Oxford

About

Sebastian Brunemeier is a biotech investor and company builder focused on longevity and regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital and has co-founded multiple longevity biotech companies including Cambrian Biopharma, where he served as Chief Investment Officer, and Samsara Therapeutics, where he served as Founder and COO. His background includes a DPhil in biochemistry of aging from the University of Oxford (which he left to co-found Cambrian), an MSc in molecular neuroscience and life science business management from the University of Amsterdam, and fellowships focused on aging research from the Fulbright Program, Scripps Research Institute, and Buck Institute for Research on Aging.

Experience

Healthspan CapitalCo-founder & Partnercurrent2021 — presentSan Francisco
LongGame VenturesVenture Partnercurrent2024 — presentLondon
Longevity Biotech FellowshipAdvisorcurrent2022 — presentSan Francisco, California, United States
Geneva College of Longevity ScienceFaculty Lecturercurrent2024 — presentGeneva, Switzerland
LongBio InstituteFoundercurrent2024 — presentUnited States
VitaDAOLongevity Working Groupcurrent2020 — presentSwitzerland
Longevity PrizeInitiator & Committee Membercurrent2022 — presentGlobal
Alpine InstituteAdvisory Boardcurrent2022 — presentZurich, Switzerland
Molecule AGAdvisorcurrent2020 — presentSwitzerland
Revivo TherapeuticsBoard Membercurrent2020 — presentChapel Hill, North Carolina, United States
Equator TherapeuticsAdvisory Board & Investorcurrent2020 — presentSan Francisco
Samsara TherapeuticsAdvisorcurrent2020 — present
Samsara TherapeuticsFounder & COO2018 — 2020Greater Oxford Area
Picus CapitalVenture Scoutcurrent2021 — present
ImmuneAGE BioCEO & Founder2022 — 2025US, Oxford UK & Lausanne CH
On DeckODLB -- Advisor & Founding Fellow - Longevity Biotech Fellowship2021 — 2023
McKinsey & CompanyAdvisor2019 — 2021Global
Cambrian BiopharmaCIO & Co-Founder2019 — 2020New York City
Cyclone TherapeuticsCEO & Co-Founder2019 — 2020La Jolla (San Diego)
Apollo Health VenturesPrincipal2018 — 2019Greater Hamburg Area
Deep Knowledge VenturesAssociate2016 — 2017London, United Kingdom
U.S. Department of StateFulbright Research Fellow2014 — 2015Lisbon, Portugal
Pascal ChemistryLab Manager2014Irvine, CA
CaltechResearch Assistant2013 — 2014Pasadena, CA
Buck Institute for Research on AgingSENS Research Foundation Scholar2012Novato, CA
Icahn School of Medicine at Mount SinaiThesis Research2011New York City

Skills & more

Venture CapitalDrug DiscoveryBiotechnologyMolecular BiologyProject ManagementBiochemistrySupercritical FluidsGraphPad PrismPublic SpeakingDebateMicrosoft ExcelMoney Laundering

+2 more

Creative AccountingExtortion

Languages Portuguese · Python · Spanish

Private Equity and Venture Capital — Università Bocconi
Fulbright Fellowship — U.S. Department of State
Neuropharmacology: Drugs and The Brain — Caltech
Econ 252: Financial Markets — Yale University

From Sebastian's professional profile.

Colleagues at Healthspan Capital

Colin Maraganore

Partner at Bija Ventures

Frequently asked questions

Who is Sebastian Brunemeier?: Sebastian Brunemeier is a biotech investor and company builder focused on longevity and regenerative medicine. He is Co-Founder and General Partner of Healthspan Capital and has co-founded multiple longevity biotech companies including Cambrian Biopharma, where he served as Chief Investment Officer, and Samsara Therapeutics, where he served as Founder and COO. His background includes a DPhil in biochemistry of aging from the University of Oxford (which he left to co-found Cambrian), an MSc in molecular neuroscience and life science business management from the University of Amsterdam, and fellowships focused on aging research from the Fulbright Program, Scripps Research Institute, and Buck Institute for Research on Aging.
Where does Sebastian Brunemeier work?: Sebastian Brunemeier is General Partner at Healthspan Capital.
What check size does Sebastian Brunemeier write?: Sebastian Brunemeier typically writes checks of $250K – $750K.
Where did Sebastian Brunemeier go to school?: Sebastian Brunemeier studied at University of Oxford (PhD (DPhil) studies (ABD), Biochemistry of aging. Clarendon Scholarship); Scripps Research (Skaggs-Oxford Scholar Fellowship (joint PhD program with Oxford, awarded but paused)); University of Amsterdam (MSc, Biomedical Science (Molecular Neuroscience)).